Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-11
1994-08-02
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514302, 546114, 546116, C07D49504, C07D491048
Patent
active
053345967
ABSTRACT:
Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2##
REFERENCES:
patent: 4064255 (1977-12-01), Champseix et al.
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5026700 (1991-06-01), Harrison
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5064814 (1991-11-01), Klein et al.
patent: 5190938 (1993-03-01), Badorc
patent: 5204469 (1993-04-01), Descamps
patent: 5252581 (1993-10-01), Effland
patent: 5260261 (1993-11-01), Prisbylla
Halczenko Wasyl
Hartman George D.
Prugh John D.
Ivy C. Warren
M. Mach D. Margaret
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64983